Provided by Tiger Trade Technology Pte. Ltd.

CMS

11.570
-0.290-2.45%
Volume:6.11M
Turnover:70.59M
Market Cap:28.15B
PE:16.11
High:12.130
Open:11.920
Low:11.420
Close:11.860
52wk High:15.449
52wk Low:9.510
Shares:2.43B
HK Float Shares:2.43B
Volume Ratio:0.62
T/O Rate:0.25%
Dividend:0.33
Dividend Rate:2.82%
EPS(LYR):0.718
ROE:8.42%
ROA:5.62%
PB:1.34
PE(LYR):16.11
PS:2.77

Loading ...

China Medical System files HKEX next-day disclosure return reporting share repurchase

Reuters
·
Jun 17

How Investors Are Reacting To China Medical System (SEHK:867) Advancing Its siRNA-Based Obesity Pipeline

Simply Wall St.
·
Jun 15

CMS Repurchases 400,000 Shares, Raising Treasury Stock to 5.50 Million

Bulletin Express
·
Jun 09

CMS Repurchases 1.01 Million Shares for HK$10.44 Million, Lifting Treasury Stock to 5.10 Million

Bulletin Express
·
Jun 08

CMS Conducts Share Buyback, Spending HK$10.44 Million on June 8

Stock News
·
Jun 08

China Medical System files HKEX next-day disclosure return reporting share buyback at HKD 10.33 each

Reuters
·
Jun 08

China Medical System files HKEX next-day return disclosing share buyback at HKD 10.55 each

Reuters
·
Jun 04

CMS Executes Share Buyback Valued at HK$9.69 Million on June 3

Stock News
·
Jun 03

CMS completes HK$9.69 million on-market buyback, treasury stock rises to 3.08 million shares

Bulletin Express
·
Jun 03

CMS Allocates HK$5.58 Million for Share Buyback on June 1

Stock News
·
Jun 01

CMS Cuts Outstanding Shares by 1.02 Million in May; Maintains Public Float Compliance

Bulletin Express
·
Jun 01

CMS Allocates Approximately HK$10.81 Million for Share Buyback on May 29

Stock News
·
May 29

China Medical System Gets China Trial Approval for Crohn's, Colitis Drug

MT Newswires Live
·
May 26

CMS Receives Regulatory Clearance for Clinical Trials of Novel TYK2 Inhibitor in Ulcerative Colitis and Crohn's Disease

Stock News
·
May 26

China Medical System Holdings - CMS-D001 Granted Drug Clinical Trial Approval by Nmpa on 25 May 2026

THOMSON REUTERS
·
May 26

AI Frenzy Shifts from Hardware to Applications, Musk-Related Concepts Gain Traction

Stock News
·
May 07

CMS (867.HK/8a8.SG) Signed an Exclusive Commercialization and Supply Agreement for Marketed Originator Intravenous Iron Products Monofer® and Cosmofer®

THOMSON REUTERS
·
Apr 27

China Medical System Holdings - Pharmacosmos to Manufacture and Supply Monofer and Cosmofer for Fifteen Years

THOMSON REUTERS
·
Apr 27

China Medical System Holdings: Nda for Mg-K10 for Seasonal Allergic Rhinitis Accepted by Nmpa in China on April 23, 2026

THOMSON REUTERS
·
Apr 23

CMS Secures NMPA Nod to Review MG-K10 NDA for Once-Monthly Treatment of Seasonal Allergic Rhinitis

Bulletin Express
·
Apr 23